- Reframe Daily
- Posts
- Reframe Daily: One-shot RSV shield, new weight-loss duo & AI home-care
Reframe Daily: One-shot RSV shield, new weight-loss duo & AI home-care
Christin Chong, PhD
June 10, 2025
Good healthcare news on 2025-06-10. We checked credible sources for you, assessed their market impact, and filtered out the bad stuff. Estimated reading time saved: 4 hours. Check here for all past issues.
Want to take charge of your health in community? See reframescience.org to study yourself like a compassionate scientist. These few days we chatted about…
a reframe science member tested the effects of boron on his testosterone levels
a reframe science member shared the joy of the 7 minute workout
how chatGPT o3 might have gotten dumber with the release of pro
how scientists stay updated in their field if they haven’t done research in a while
Interested? Schedule a chat with me to see if the reframe science community is right for you!
Let me know what news sources and peer-reviewed journals you’d like us to add, and any feedback you have to make this newsletter more useful to you! I read every email.
- Christin Chong (neuroscience PhD, chaplain, healthcare marketer, at your service)
Headline | Why it’s good news | Market-readiness (😊) |
|---|---|---|
Babies will soon get a one-shot medicine that keeps a nasty lung virus away. | 😊😊😊😊😊 | |
Novo Nordisk launches big final-stage test of obesity drug CagriSema | A new weight-loss shot is entering a large study that could help people shed more pounds. | 😊😊😊 |
Extra funding will help finish a smart headband that lets users fall asleep faster. | 😊😊 | |
Hellocare.ai teams up with Mayo Clinic on smarter at-home care | Mayo’s doctors will use Hellocare’s tools so nurses can watch and help patients from anywhere. | 😊😊😊😊😊 |
Doctor software now gives quick AI hints, so patients can get care sooner. | 😊😊😊😊😊 | |
ScaleReady awards G-Rex® grant to Immuneel for cheaper CAR-T therapy | The grant will help make custom cancer-fighting cells faster and less costly. | 😊 |
| Rating key | | 1 😊 = lab stage 2 😊😊 = early pilot 3 😊😊😊 = late trial 4 😊😊😊😊 = just approved 5 😊😊😊😊😊 = on the market |